Skip to main content

Table 2 Index Benzodiazepine Prescribed to Incident and Continuing Benzodiazepine Users by Age

From: Prescription characteristics associated with drug overdose risk among adults prescribed benzodiazepines: a cohort study

Medication, n (%)a

Incident

Continuing

 < 65

N = 105,737

65 + 

N = 385,951

 < 65

N = 240,358

65 + 

N = 508,230

Alprazolam

24,559 (23.2)

135,082 (35.0)

73,624 (30.6)

185,634 (36.5)

Lorazepam

33,086 (31.3)

126,578 (32.8)

52,716 (21.9)

148,040 (29.1)

Clonazepam

18,715 (17.7)

33,977 (8.8)

72,094 (30)

84,809 (16.7)

Diazepam

24,228 (22.9)

62,224 (16.1)

32,879 (13.7)

47,370 (9.3)

Temazepam

4,367 (4.1)

23,530 (6.1)

9,623 (4.0)

36,087 (7.1)

Clorazepate

237 (0.2)

2,043 (0.5)

831 (0.3)

4,523 (0.9)

Chlordiazepoxide

466 (0.4)

1,732 (0.4)

443 (0.2)

2,247 (0.4)

Triazolam

237 (0.2)

1,280 (0.3)

342 (0.1)

1,470 (0.3)

Oxazepam

61 (0.1)

352 (0.1)

180 (0.1)

1,006 (0.2)

Flurazepam

24 (0)

201 (0.1)

93 (0)

323 (0.1)

  1. BZD Benzodiazepine
  2. aList includes the top 10 index BZD prescribed to the continuing 65 + cohort (i.e., the largest group) in descending order. Percentages in a given cohort may sum to > 100% because some beneficiaries filled > 1 index BZD prescription. Estazolam, midazolam, and clobazam each accounted for < 0.1% of BZD fills to the continuing 65 + cohort and are not shown